"Presence of Poor Prognostic Factors May Predict Response to Abatacept in Patients With Active Psoriatic Arthritis: Results From a Post Hoc Analysis of a Phase III Study. Association of Women in Rheumatology (AWIR), SC, Aug 2017." by Philip Mease

Presentation

Presence of Poor Prognostic Factors May Predict Response to Abatacept in Patients With Active Psoriatic Arthritis: Results From a Post Hoc Analysis of a Phase III Study. Association of Women in Rheumatology (AWIR), SC, Aug 2017.

Association of Women in Rheumatology (AWIR) (2017)

Philip Mease, Providence St. Joseph Health
et.al.

Link

Disciplines

Rheumatology

Publication Date

August, 2017

Citation Information

Philip Mease and et.al.. "Presence of Poor Prognostic Factors May Predict Response to Abatacept in Patients With Active Psoriatic Arthritis: Results From a Post Hoc Analysis of a Phase III Study. Association of Women in Rheumatology (AWIR), SC, Aug 2017." Association of Women in Rheumatology (AWIR) (2017)
Available at: http://works.bepress.com/philip-mease/186/